French pharmaceutical firm Sanofi-Aventis has bolstered its presence in Mexico through the acquisition of generics company Laboratorios Kendrick. The acquisition is part of an industry-wide shift in focus, with leading pharmaceutical companies increasingly looking to make in-roads into emerging markets which are set to drive future revenues.
US biotech Novavax has initiated a pivotal two-stage study for its H1N1 influenza vaccine in Mexico. Novavax's strategy of pursuing approval for the vaccine in smaller markets before targeting the US represents an alternative and faster route to market. Given the many benefits of this strategy, Datamonitor believes that it may be adopted by other small vaccine companies in the future.
Edit my basket
© Datamonitor 2014. All rights reserved
Terms & Conditions